Shopping Cart 0
Cart Subtotal
AED 0

Clinuvel Pharmaceuticals Ltd (CUV) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Clinuvel Pharmaceuticals Ltd (CUV)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Clinuvel Pharmaceuticals Ltd (Clinuvel Pharmaceuticals) is a biopharmaceutical company which focuses on the development of drugs for the treatment of severe skin disorders. Its lead product candidate, Scenesse (afamelanotide) is a first-in-class drug targeting erythropoietic protoporphyria (EPP). Scenesse is aimed to provide skin protection against UV radiation (UVR) as it stimulates the body's natural ability to produce melanin, the dark pigment of the skin known to have photoprotective properties. The company has operations in Australia, Switzerland and the US. Clinuvel Pharmaceuticals is headquartered in Melbourne, Victoria, Australia.

Clinuvel Pharmaceuticals Ltd Key Recent Developments

Oct 29,2018: CLINUVEL expands Singapore laboratory facilities

Aug 29,2018: CLINUVEL delivers second positive financial result

Jul 30,2018: Clinuvel Pharmaceuticals: appendix 4C

Feb 28,2018: CLINUVEL sustains profitability first-half of year

Feb 20,2018: CLINUVEL unveils new global positioning

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Clinuvel Pharmaceuticals Ltd-Key Facts 5

Clinuvel Pharmaceuticals Ltd-Key Employees 6

Clinuvel Pharmaceuticals Ltd-Key Employee Biographies 7

Clinuvel Pharmaceuticals Ltd-Major Products and Services 8

Clinuvel Pharmaceuticals Ltd-History 9

Clinuvel Pharmaceuticals Ltd-Company Statement 12

Clinuvel Pharmaceuticals Ltd-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 16

Company Overview 16

Clinuvel Pharmaceuticals Ltd-Business Description 17

Clinuvel Pharmaceuticals Ltd-SWOT Analysis 18

SWOT Analysis-Overview 18

Clinuvel Pharmaceuticals Ltd-Strengths 18

Clinuvel Pharmaceuticals Ltd-Weaknesses 19

Clinuvel Pharmaceuticals Ltd-Opportunities 20

Clinuvel Pharmaceuticals Ltd-Threats 21

Clinuvel Pharmaceuticals Ltd-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Clinuvel Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Clinuvel Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Clinuvel Pharmaceuticals Ltd, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Oct 29, 2018: CLINUVEL expands Singapore laboratory facilities 32

Aug 29, 2018: CLINUVEL delivers second positive financial result 33

Jul 30, 2018: Clinuvel Pharmaceuticals: appendix 4C 34

Feb 28, 2018: CLINUVEL sustains profitability first-half of year 36

Feb 20, 2018: CLINUVEL unveils new global positioning 37

Jan 31, 2018: Clinuvel Pharmaceuticals: Appendix 4C 39

Oct 30, 2017: Clinuvel Pharmaceuticals: Appendix 4C 40

Oct 04, 2017: Elie Ishag to Retire from Clinuvel Board 41

Jul 31, 2017: Clinuvel Pharmaceuticals: Quarterly Cashflow report for the period ended 30 June 2017 42

Apr 28, 2017: Clinuvel Pharmaceuticals: Appendix 4C-Quarterly report 43

Section 6-Appendix 44

Methodology 44

Ratio Definitions 44

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

Clinuvel Pharmaceuticals Ltd, Performance Chart (2014-2018) 26

Clinuvel Pharmaceuticals Ltd, Ratio Charts 28

Clinuvel Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Clinuvel Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30


List Of Table

List of Tables

Clinuvel Pharmaceuticals Ltd, Key Facts 5

Clinuvel Pharmaceuticals Ltd, Key Employees 6

Clinuvel Pharmaceuticals Ltd, Key Employee Biographies 7

Clinuvel Pharmaceuticals Ltd, Major Products and Services 8

Clinuvel Pharmaceuticals Ltd, History 9

Clinuvel Pharmaceuticals Ltd, Other Locations 14

Clinuvel Pharmaceuticals Ltd, Subsidiaries 14

Clinuvel Pharmaceuticals Ltd, Key Competitors 22

Clinuvel Pharmaceuticals Ltd, Ratios based on current share price 23

Clinuvel Pharmaceuticals Ltd, Annual Ratios 24

Clinuvel Pharmaceuticals Ltd, Annual Ratios (Cont...1) 25

Clinuvel Pharmaceuticals Ltd, Interim Ratios 27

Clinuvel Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Clinuvel Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Clinuvel Pharmaceuticals Ltd, Recent Deals Summary 31

Currency Codes 44

Capital Market Ratios 44

Equity Ratios 45

Profitability Ratios 45

Cost Ratios 46

Liquidity Ratios 46

Leverage Ratios 47

Efficiency Ratios 47

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Clinuvel Pharmaceuticals Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Opthea Ltd

MEI Pharma Inc

Immune System Therapeutics Ltd

EnGeneIC Ltd

biosensis Pty Ltd

Clinuvel Pharmaceuticals Ltd (CUV)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Clinuvel Pharmaceuticals Ltd (Clinuvel Pharmaceuticals) is a biopharmaceutical company which focuses on the development of drugs for the treatment of severe skin disorders. Its lead product candidate, Scenesse (afamelanotide) is a first-in-class drug targeting erythropoietic protoporphyria (EPP). Scenesse is aimed to provide skin protection against UV radiation (UVR) as it stimulates the body's natural ability to produce melanin, the dark pigment of the skin known to have photoprotective properties. The company has operations in Australia, Switzerland and the US. Clinuvel Pharmaceuticals is headquartered in Melbourne, Victoria, Australia.

Clinuvel Pharmaceuticals Ltd Key Recent Developments

Oct 29,2018: CLINUVEL expands Singapore laboratory facilities

Aug 29,2018: CLINUVEL delivers second positive financial result

Jul 30,2018: Clinuvel Pharmaceuticals: appendix 4C

Feb 28,2018: CLINUVEL sustains profitability first-half of year

Feb 20,2018: CLINUVEL unveils new global positioning

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Clinuvel Pharmaceuticals Ltd-Key Facts 5

Clinuvel Pharmaceuticals Ltd-Key Employees 6

Clinuvel Pharmaceuticals Ltd-Key Employee Biographies 7

Clinuvel Pharmaceuticals Ltd-Major Products and Services 8

Clinuvel Pharmaceuticals Ltd-History 9

Clinuvel Pharmaceuticals Ltd-Company Statement 12

Clinuvel Pharmaceuticals Ltd-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 16

Company Overview 16

Clinuvel Pharmaceuticals Ltd-Business Description 17

Clinuvel Pharmaceuticals Ltd-SWOT Analysis 18

SWOT Analysis-Overview 18

Clinuvel Pharmaceuticals Ltd-Strengths 18

Clinuvel Pharmaceuticals Ltd-Weaknesses 19

Clinuvel Pharmaceuticals Ltd-Opportunities 20

Clinuvel Pharmaceuticals Ltd-Threats 21

Clinuvel Pharmaceuticals Ltd-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Clinuvel Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Clinuvel Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Clinuvel Pharmaceuticals Ltd, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Oct 29, 2018: CLINUVEL expands Singapore laboratory facilities 32

Aug 29, 2018: CLINUVEL delivers second positive financial result 33

Jul 30, 2018: Clinuvel Pharmaceuticals: appendix 4C 34

Feb 28, 2018: CLINUVEL sustains profitability first-half of year 36

Feb 20, 2018: CLINUVEL unveils new global positioning 37

Jan 31, 2018: Clinuvel Pharmaceuticals: Appendix 4C 39

Oct 30, 2017: Clinuvel Pharmaceuticals: Appendix 4C 40

Oct 04, 2017: Elie Ishag to Retire from Clinuvel Board 41

Jul 31, 2017: Clinuvel Pharmaceuticals: Quarterly Cashflow report for the period ended 30 June 2017 42

Apr 28, 2017: Clinuvel Pharmaceuticals: Appendix 4C-Quarterly report 43

Section 6-Appendix 44

Methodology 44

Ratio Definitions 44

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

Clinuvel Pharmaceuticals Ltd, Performance Chart (2014-2018) 26

Clinuvel Pharmaceuticals Ltd, Ratio Charts 28

Clinuvel Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Clinuvel Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30


List Of Table

List of Tables

Clinuvel Pharmaceuticals Ltd, Key Facts 5

Clinuvel Pharmaceuticals Ltd, Key Employees 6

Clinuvel Pharmaceuticals Ltd, Key Employee Biographies 7

Clinuvel Pharmaceuticals Ltd, Major Products and Services 8

Clinuvel Pharmaceuticals Ltd, History 9

Clinuvel Pharmaceuticals Ltd, Other Locations 14

Clinuvel Pharmaceuticals Ltd, Subsidiaries 14

Clinuvel Pharmaceuticals Ltd, Key Competitors 22

Clinuvel Pharmaceuticals Ltd, Ratios based on current share price 23

Clinuvel Pharmaceuticals Ltd, Annual Ratios 24

Clinuvel Pharmaceuticals Ltd, Annual Ratios (Cont...1) 25

Clinuvel Pharmaceuticals Ltd, Interim Ratios 27

Clinuvel Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Clinuvel Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Clinuvel Pharmaceuticals Ltd, Recent Deals Summary 31

Currency Codes 44

Capital Market Ratios 44

Equity Ratios 45

Profitability Ratios 45

Cost Ratios 46

Liquidity Ratios 46

Leverage Ratios 47

Efficiency Ratios 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Clinuvel Pharmaceuticals Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Opthea Ltd

MEI Pharma Inc

Immune System Therapeutics Ltd

EnGeneIC Ltd

biosensis Pty Ltd